Complex Percutaneous Coronary Intervention Market Size, Share, Industry Trends and Forecast to 2030

Complex Percutaneous Coronary Intervention Market Size & CAGR in 2021:

The global complex percutaneous coronary intervention market is expected to reach a market size of USD 5.4 billion in 2021 with a Compound Annual Growth Rate (CAGR) of 4.2% from 2021 to 2025. The market is projected to witness significant growth due to the increasing prevalence of coronary artery disease and the advancements in minimally invasive techniques.

COVID-19 Impact on Complex Percutaneous Coronary Intervention Market:

The COVID-19 pandemic had a significant impact on the complex percutaneous coronary intervention market. The restrictions imposed to curb the spread of the virus led to delays in elective procedures, including complex PCI. However, as healthcare systems adapted to the new normal, the market witnessed a gradual recovery with the adoption of telemedicine and stringent safety protocols.

Complex Percutaneous Coronary Intervention Dynamics:

Complex percutaneous coronary intervention involves the use of advanced techniques and devices to treat complex coronary artery lesions. The market dynamics are influenced by factors such as technological advancements, increasing geriatric population, rising prevalence of cardiovascular diseases, and the growing demand for minimally invasive procedures.

Segments and Related Analysis:

The complex percutaneous coronary intervention market can be segmented based on the type of procedure, device type, end-user, and region. The key segments include drug-eluting stents, bioresorbable stents, angioplasty balloons, atherectomy devices, imaging systems, and others. Each segment plays a crucial role in the overall market dynamics.

By Region Analysis:

The complex percutaneous coronary intervention market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest market share due to the presence of advanced healthcare infrastructure, high adoption of innovative technologies, and increasing prevalence of cardiovascular diseases. Europe and Asia Pacific are also expected to witness significant growth in the coming years.

Key Market Players and Competitive Landscape:

Key players in the complex percutaneous coronary intervention market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Cardinal Health, Inc., and others. The competitive landscape is characterized by strategic partnerships, product launches, acquisitions, and collaborations to gain a competitive edge in the market.

Recent Happenings in Complex Percutaneous Coronary Intervention Market:

- In May 2021, Abbott Laboratories launched a new drug-eluting stent for complex coronary lesions, enhancing its product portfolio in the market. - In June 2021, Boston Scientific Corporation acquired a leading imaging systems company to strengthen its position in the complex percutaneous coronary intervention market. - In August 2021, Medtronic introduced a next-generation atherectomy device for the treatment of complex coronary artery disease, expanding its product offerings.